Two Sigma Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,811
Closed -$297K 2322
2024
Q4
$297K Sell
2,811
-978
-26% -$105K 0.04% 655
2024
Q3
$409K Buy
3,789
+1,811
+92% +$198K 0.01% 1483
2024
Q2
$215K Buy
+1,978
New +$233K ﹤0.01% 2300
2024
Q1
Sell
-4,064
Closed -$508K 3758
2023
Q4
$495K Buy
+4,064
New +$453K ﹤0.01% 1566
2022
Q3
Sell
-3,563
Closed -$374K 3194
2022
Q2
$374K Buy
+3,563
New +$423K 0.01% 1124
2020
Q3
Sell
-5,924
Closed -$774K 1706
2020
Q2
$686K Buy
+5,924
New +$683K 0.02% 509
2020
Q1
Sell
-3,173
Closed -$461K 2449
2019
Q4
$461K Buy
+3,173
New +$438K ﹤0.01% 1488
2019
Q1
Sell
-3,453
Closed -$392K 2543
2018
Q4
$348K Sell
3,453
-10,056
-74% -$1.13M ﹤0.01% 1241
2018
Q3
$1.72M Buy
13,509
+6,303
+87% +$749K 0.01% 789
2018
Q2
$780K Buy
+7,206
New +$784K ﹤0.01% 1501
2018
Q1
Sell
-2,564
Closed -$298K 3003
2017
Q4
$300K Buy
+2,564
New +$290K 0.01% 1002
2017
Q3
Sell
-1,907
Closed -$238K 1260
2017
Q2
$238K Sell
1,907
-276
-13% -$32.7K 0.05% 460
2017
Q1
$259K Buy
+2,183
New +$247K 0.05% 453
2016
Q4
Sell
-4,732
Closed -$597K 985
2016
Q3
$597K Buy
+4,732
New +$585K 0.2% 123

Other funds holding ZBH

Two Sigma Securities's ZBH Position: Q1 2025 in Review

Two Sigma Securities sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,811 shares — an estimated $297K sold.

Two Sigma Securities first reported a position in ZBH in Q3 2016 and held it in 14 quarters. The position peaked at $1.72M in Q3 2018. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Two Sigma Securities reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,811 Zimmer Biomet shares in Q1 2025, an estimated $297K.
  • Two Sigma Securities first reported a position in Zimmer Biomet in Q3 2016 and held it in 14 quarters.
  • Two Sigma Securities's Zimmer Biomet position peaked at $1.72M in Q3 2018.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.